<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58374</article-id><article-id pub-id-type="doi">10.7554/eLife.58374</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-188186"><name><surname>Oliemuller</surname><given-names>Erik</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4506-0504</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188187"><name><surname>Newman</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188188"><name><surname>Tsang</surname><given-names>Siu Man</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188189"><name><surname>Foo</surname><given-names>Shane</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188190"><name><surname>Muirhead</surname><given-names>Gareth</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188191"><name><surname>Noor</surname><given-names>Farzana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188193"><name><surname>Haider</surname><given-names>Syed</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188192"><name><surname>Aurrekoetxea-Rodríguez</surname><given-names>Iskander</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23474"><name><surname>Vivanco</surname><given-names>Maria dM</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-112254"><name><surname>Howard</surname><given-names>Beatrice A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9162-0314</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research</institution>, <institution>The Institute of Cancer Research, London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">The Breast Cancer Now Toby Robins Research Centre,  Division of Breast Cancer Research</institution>, <institution>The Institute of Cancer Research, London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Translational Immunotherapy Team, Division of Radiotherapy and Imaging,</institution>, <institution>The Institute of Cancer Research, London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Basque Research and Technology Alliance (BRTA)</institution>, <institution>CIC bioGUNE</institution>, <addr-line><named-content content-type="city">Derio</named-content></addr-line>, <country>Spain</country></aff><aff id="aff5"><institution content-type="dept">Cell Biology and Stem Cells Unit</institution>, <institution>CIC bioGUNE</institution>, <addr-line><named-content content-type="city">Derio</named-content></addr-line>, <country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-75453"><name><surname>Macleod</surname><given-names>Kay F</given-names></name><role>Reviewing editor</role><aff><institution>University of Chicago</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>beatrice.howard@icr.ac.uk</email> (BH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>09</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58374</elocation-id><history><date date-type="received"><day>28</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>09</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Oliemuller et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Oliemuller et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58374-v1.pdf"/><abstract><p>SOX11 is an embryonic mammary epithelial marker that is normally silenced prior to birth. High <italic>SOX11</italic> levels in breast tumours are significantly associated with distant metastasis and poor outcome in breast cancer patients. Here, we show that SOX11 confers distinct features to ER-negative DCIS.com breast cancer cells, leading to populations enriched with highly plastic hybrid epithelial/mesenchymal cells, which display invasive features and alterations in metastatic tropism when xenografted into mice. We found that SOX11+DCIS tumour cells metastasize to brain and bone at greater frequency and to lungs at lower frequency compared to cells with lower SOX11 levels. High levels of SOX11 leads to the expression of markers associated with mesenchymal state and embryonic cellular phenotypes. Our results suggest that SOX11 may be a potential biomarker for breast tumours with elevated risk of developing metastases and may require more aggressive therapies.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007913</institution-id><institution>Breast Cancer Now</institution></institution-wrap></funding-source><award-id>Programme Funding to the Breast Cancer Now Toby Robins Research Centre</award-id><principal-award-recipient><name><surname>Oliemuller</surname><given-names>Erik</given-names></name><name><surname>Newman</surname><given-names>Richard</given-names></name><name><surname>Tsang</surname><given-names>Siu Man</given-names></name><name><surname>Muirhead</surname><given-names>Gareth</given-names></name><name><surname>Noor</surname><given-names>Farzana</given-names></name><name><surname>Haider</surname><given-names>Syed</given-names></name><name><surname>Howard</surname><given-names>Beatrice A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>CRUK: A21855</award-id><principal-award-recipient><name><surname>Foo</surname><given-names>Shane</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Spanish Ministry of Education and Science</institution></institution-wrap></funding-source><award-id>SAF2017-84934-R</award-id><principal-award-recipient><name><surname>Vivanco</surname><given-names>Maria dM</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Government of the Autonomous Community of the Basque Country, the Department of Industry, Tourism and Trade</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Aurrekoetxea-Rodríguez</surname><given-names>Iskander</given-names></name><name><surname>Vivanco</surname><given-names>Maria dM</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal work was carried out under UK Home Office PPL number: PB0FA698C  (BAH Project licence holder) and personal licenses following local ethical approval of all protocols from The Institute of Cancer Research Ethics Committee and in accordance with local and national guidelines.  All surgery was performed under isoflurane anesthesia with appropriate analgesia, and every effort was made to minimise suffering.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in ArrayExpress as accession E-MTAB-9108. All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Oliemuller E</collab><collab>Howard BA</collab></person-group><year iso-8601-date="2020">2020</year><source>RNA-seq of DCIS-pInducer21-SOX11 cells grown in 2D and 3D</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-9108/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-9108/</ext-link><comment>EBI, E-MTAB-9108</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-58374-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>